Heart failure & cardiomyopathies

Proteomics Identify Clinical Phenotypes and Predict Functional Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From VITALITY-HFpEF

Circ Heart FailPublished Secondary analysis of the VITALITY-HFpEF randomised trial

Authors' conclusion

Proteomics differentiate specific baseline functional traits associated with HFpEF and may facilitate phenotyping in a heterogeneous disease.

Study context

Population
Heart failure with preserved ejection fraction (HFpEF) patients with LVEF ≥45% and a HF decompensation event within 6 months368 proteins evaluated
Participants
763 patients
Primary endpoint
Associations of protein clusters with clinical characteristics and functional outcomes (KCCQ Physical Limitation Score, 6-minute walk distance, Fried frailty phenotype)
Follow-up
Baseline and 24 weeks
Methodological detailsproteomic analysis, prerandomization blood samples
  • Proteomic analysis
  • Prerandomization blood samples

Primary result

As reported in the abstract

Baseline proteomic summary composite predicted 24-week change in KCCQ Physical Limitation Score

r=0.42

P<0.001

Baseline proteomic summary composite predicted 24-week change in 6-minute walk distance

r=0.30

P<0.001

Original publication

Proteomics Identify Clinical Phenotypes and Predict Functional Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From VITALITY-HFpEF. Circ Heart Fail. Published 29 August 2024. doi:10.1161/circheartfailure.124.011792

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.